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Abstract
Replication-defective adenoviruses (Ad) utilized as vectors for gene transfer are known to induce an inflammatory and immune response
upon exposure to respiratory cells in vitro and in vivo. Among the different mediators of inflammation, we recently demonstrated that a
replication-defective Ad serotype 5, deleted in the early genes E1 and E3 (Ad.CFTR), induces the proinflammatory intercellular adhesion
molecule 1 (ICAM-1) in A549 respiratory cells in vitro and in lung portions of nonhuman primates in vivo (E. Nicolis et al., 1998, Gene
Ther. 5, 131–136). More recently, we described the involvement of the nuclear factor B (NF-B) in the induction of ICAM-1 upon 24 h
of exposure of the same Ad5-derived vector (P. Melotti et al., 2001, Gene Ther. 8, 1436–1442). Here we investigated whether the early
phase of virus–cell interaction is sufficient to stimulate ICAM-1 upregulation. A549 cells were exposed to wild-type Ad5 (Ad5), to
Ad.CFTR, and to Ad5 inactivated by incubation at 56°C (Ad5/56°C). Ad5, Ad.CFTR, and Ad5/56°C activated NF-B and increased
ICAM-1 mRNA levels within 4 h after exposure. The role of the mitogen-activated protein kinases (MAPKs) on the ICAM-1 mRNA
induction was studied. ICAM-1 mRNA upregulation was inhibited upon incubation with several chemicals, namely, the ERK1/2 inhibitors
PD98059 and AG1288 (by 98 and 67%, respectively), of the p38/MAPK pathway SB203580 (by 50%), of the JNK pathway dimethyl-
aminopurine (by 83%), and of the NF-B parthenolide (by 96%). Ad5 and Ad5/56°C stimulated ERK1/2, p38/MAPK, and JNK1 starting
10 min and peaking 20–30 min after exposure. The present results indicate a link between the activation of the three major MAPK pathways,
NF-B, and the upregulation of ICAM-1 gene expression evoked by Ad5 in the very initial phase of infection.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Adenovirus (Ad)2 is a double-stranded DNA nonenvel-
oped virus. Ad serotypes 2 (Ad2) and 5 (Ad5) are known to
be tropic for the respiratory tract, causing mild respiratory
infections. Nonreplicative Ad2 and Ad5 have been exten-
sively studied for their ability to transfer potential therapeu-
tic genes both in vitro and in vivo, including the cystic
fibrosis gene into airway cells. Even though these vectors
present several attractive features, their in vivo administra-
tion is often associated with inflammation, which consti-
tutes a serious limitation in their use (Boucher, 1999). Dif-
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ferent soluble mediators of inflammation are expressed
upon infection of respiratory cells with wild-type or repli-
cation-defective Ad2 and Ad5 in vitro and in vivo, namely
interleukin-1 (Schwartz et al., 1999), tumor necrosis fac-
tor- (Zsengeller et al., 2000), interleukin-6 (Ginsberg et al.,
1991; McElvaney and Crystal, 1995), interleukin-8 (Amin
et al., 1995; Bruder and Kovesdi, 1997), and macrophage
inflammatory protein-2/1- (Zsengeller et al., 2000). Also,
Ad5 induces the intercellular adhesion molecule-1
(ICAM-1) involved in the inflammatory and immune re-
sponses both in A549 cells in vitro and in lung portions of
nonhuman primates in vivo, as reported by other and our
laboratory (Stark et al., 1996; Melotti et al., 2001; Nicolis et
al., 1998).
Little is known on the mechanisms that initiate the first
phase of inflammation following adenovirus infection. Cel-
lular transcription factors involved in gene expression of
cytokines and adhesion molecules are activated by upstream
phosphorylation events (Carter et al., 1999a, 1999b; De
Cesaris et al., 1999; Papi and Johnston, 1999). Among
these, mitogen-activated protein kinases (MAPKs), which
transactivate several transcription factors (Treisman, 1996;
Garrington and Johnson, 1999), are known to be induced by
respiratory viruses (Alcorn et al., 2001; Bruder and
Kovesdi, 1997; Chen et al., 2000; Griego et al., 2000;
Kujime et al., 2000; Soumalainen et al., 2001; Tibbles et al.,
2002). For instance, it has been reported that Ad5 stimulates
the Raf/MAPK and p38/MAPK kinase pathways, respira-
tory syncytial virus the extracellular signal-regulated kinase
2 (ERK2) pathway, and the rhinovirus p38/MAPK kinase,
in bronchial or alveolar type II-derived A549 cells in vitro
(Bruder and Kovesdi, 1997; Chen et al., 2000; Griego et al.,
2000; Soumalainen et al., 2001). MAPKs are activated by
dual phosphorylation on specific tyrosine and threonine
residues in response to various external and internal stimuli
(Dhanasekaran and Reddy, 1998; Schaffer and Weber,
1999). They are hierarchically arranged and typically orga-
nized in pathways consisting of a MAPK, a MAPK activator
(MEK, MKK, or MAPK kinase), and a MEK activator
(MEK kinase, MEKK, or MAPK kinase kinase) (Widmann
et al., 1999). Transmission of signals is achieved by sequen-
tial phosphorylation and activation of the components of
specific cascades. In mammalian cells, three MAPK mod-
ules have been well characterized so far. They include the
ERK1/2, which preferentially regulate cell growth and dif-
ferentiation; the c-Jun N-terminal kinase; and the p38 cas-
cades, which function mainly in responses to stress, like
inflammation and apoptosis (Chang and Karin, 2001). Fol-
lowing activation, MAPKs can induce nuclear transcription
factors which regulate gene expression (Cohen, 1997). A
schematic representation of the major MAPK pathways is
presented in Fig. 1. ICAM-1 is induced in a variety of cells
including fibroblasts, leukocytes, and endothelial and epi-
thelial cells (Roebuck and Finnegan, 1999), and it can be
upregulated in response to numerous inducing factors like
the bacterial lipopolysaccharide (Fakler et al., 2000), the
proinflammatory cytokines tumor necrosis factor-
(TNF-) and interleukin-1 (IL-1) (Roebuck and Finnegan,
1999), and respiratory viruses (Stark et al., 1996; Chini et
al., 1998; Nicolis et al., 1998; Papi and Johnston, 1999;
Wang et al., 2000). It has been reported that the major
intracellular signal transduction pathways involved in the
activation of ICAM-1 gene expression at the transcriptional
level include protein kinase C (Rahman et al., 2000), the
MAPK JNK (c-Jun kinase; De Cesaris et al., 1999), and the
transcription factor nuclear factor (NF)-B signaling cas-
cade (Roebuck and Finnegan, 1999), which has been al-
ready found involved in Ad5-dependent nuclear transcrip-
tion (Borgland et al., 2000; Morelli et al., 2000), including
the long-term activation of ICAM-1 (Melotti et al., 2001).
As depicted in Fig. 1, the ICAM-1 promoter contains con-
sensus-binding sites for transcription factors, such as AP-1,
Ets-1, C/EBP, and AP-1/Ets (Roebuck and Finnegan, 1999;
Roy et al., 2001). These sequences have been related to
MAPK-dependent transcription factors (Cohen, 1997), be-
cause C/EBP, AP-1, and Ets-1 have been described as
targets of ERK1/2 (Pulverer et al., 1991; Nakajima et al.,
1993; Wasylyk et al., 1998), C/EBP and AP-1/Ets of p38/
MAPK (Wasylyk et al., 1998; Baldassare et al., 1999), and
AP-1 of JNK (Davis, 2000).
Therefore, we focused the present investigation on the
potential role of MAPK in the early signaling events elicited
by Ad5 in relation to the upregulation of the inflammatory
adhesion molecule ICAM-1, in the model of the A549 cells
in vitro. The involvement of MAPK was addressed first by
chemical inhibitors of MAPK cascades and NF-B on
ICAM-1 mRNA levels, and then by direct analysis of
MAPK enzyme activity and NF-B activation in the early
period following exposure of Ad5, E1–E3-deleted replica-
tion-defective Ad5-derived vector carrying the CFTR gene
(Ad. CFTR), and wild-type Ad5 incubated at 56°C (Ad5/
56°C) to A549 cells. We conclude that Ad5 rapidly induces
the activation of the three main MAPK pathways and of
NF-B, which are involved in the upregulation of ICAM-1
gene transcription.
Results
Modulation of Ad5-dependent ICAM-1 mRNA by
inhibitors of MAPKs and NF-B
The role of MAPKs has been first investigated by study-
ing the levels of ICAM-1 mRNA upon exposure of Ad5 to
A549 cells for 4 h, either in the presence or in the absence
of MAPKs and NF-B inhibitors, which have been incu-
bated with cells before virus addition, as described under
Materials and methods. A schematic representation of the
kinase target of each inhibitor is shown in Fig. 1. Under our
experimental conditions, Ad5 did not produce significant
cell toxicity, as demonstrated by the similar kinetics of the
cell proliferation assay reported in Fig. 2D, and incubation
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of A549 cells with the inhibitors alone did not significantly
modify the basal levels of ICAM-1 mRNA (data not
shown). The effect of different MAPK inhibitors on Ad5-
dependent ICAM-1 mRNA upregulation is presented in Fig.
2A. Because Ad5 has been reported to stimulate the Raf/
MAPK signaling pathway, leading to induction of interleu-
kin-8 (Bruder and Kovesdi, 1997), we treated A549 cells
with the tyrphostin AG1288, which is known to inhibit the
kinase activity of ERK1/ERK2 (Levitzki, 1992). AG1288
(200 M) downregulated the Ad5-induced ICAM-1 mRNA
expression by an average of 67%. PD98059 (50 M), which
inhibits MEK-1 on ERK activity (Alessi et al., 1995; Ro-
dems and Spector, 1998), abolished almost completely Ad5-
dependent induction of ICAM-1 mRNA. Because Ad2 has
been reported to transiently upregulate the p38/MAPK cas-
cade (Soumalainen et al., 2001), we tested the effect of the
SB203580 inhibitor (10 M) (Beyaert et al., 1996), which
reduced Ad5-dependent ICAM-1 mRNA upregulation by an
average of 51%. Because JNK/SAPK (stress-activated pro-
tein kinase) plays an important role on TNF--induced
ICAM-I expression (De Cesaris et al., 1999; Kobuchi et al.,
1999), A549 cells have been treated with dimethylaminopu-
rine (DMAP) which inhibits JNK/SAPK by increasing the
expression of the mitogen-activated protein phosphatase 2
(De Cesaris et al., 1999). DMAP (1 mM) reduced ICAM-1
mRNA expression by an average of 83%. Because NF-B
has been involved in ICAM-1 gene expression (Papi and
Johnston, 1999), we tested the effect of the sesquiterpene
lactone parthenolide, which is known to inhibit NF-B-
dependent gene transcription by preventing degradation of
IB- and IB- (Hehner et al., 1999). Parthenolide (10
M) inhibited almost completely Ad5-dependent ICAM-1
mRNA induction (average inhibition by 96%). To exclude
that the effect of the chemical inhibitors is due to a reduc-
tion of the infection efficiency, this has been checked by a
fluorescent focus assay. Under the same experimental con-
ditions, the number of fluorescent foci upon incubation with
Ad5 in the presence of the inhibitors did not decrease
significantly in respect to Ad5 alone (Ad5 alone, 893 324;
Ad5 and AG1288, 1218 574; Ad5 and PD98059, 1157
545; Ad5 and SB203580, 743  184; Ad5 and DMAP, 940
 571; Ad5 and parthenolide, 916 388; mean  SD, n 
6). Taken together, these results suggest a cooperation of
ERK1/ERK2, JNK/SAPK, p38/MAPK, and NF-B on the
Ad5-dependent upregulation of ICAM-1 mRNA.
Because we previously observed that Ad.CFTR upregu-
lates ICAM-1 mRNA upon 24 h of exposure (Melotti et al.,
2001), we checked whether transcription of viral genes is
Fig. 1. MAPKs pathways. Schematic representation of the MAPKs and NF-B signal transduction pathways described in the text. The target of each chemical
inhibitor is indicated by dashed arrows. Transcription consensus sequences identified on the ICAM-1 gene promoter relevant to the MAPK and NF-B
pathways are reported. Solid arrows indicate the major pathways of the activation cascade.
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absolutely necessary to elicit ICAM-1 induction in a shorter
time scale. To this purpose we utilized the replication-
defective Ad.CFTR vector. Also, we incubated Ad5/56°C
before exposure to A549 cells. This treatment allows dis-
sociation of fiber and penton base from the capsid rendering
the virus non infectious, while the fiber is still conserving its
characteristic morphology (Russell et al., 1967). Ad5 was
also incubated at 99°C (Ad5/99°C) to obtain a control for
both virus dissociation and protein denaturation. To confirm
that under our experimental conditions the treatment at
Fig. 2. ICAM-1 mRNA expression. (A) Effect of MAPK and NF-B inhibitors on Ad5-dependent ICAM-1 mRNA induction. A549 cells were incubated with
inhibitors AG1288 (200 M for 2 h), PD98059 (50 M for 1 h), SB203580 (10 M for 1 h), DMAP (1 mM for 15 min), parthenolide (10 M for 1 h), or
their solvents before exposure to Ad5 (800 M.O.I.) for an additional 4 h before RNA extraction. Results are expressed as ICAM-1 mRNA fold induction over
the basal transcript level, which has been measured after addition of the solvent alone in paired experiments with Ad  the inhibitors. Data are means 
SEM of n independent experiments (AG1288 n  4, PD98059 n  4, SB203580 n  4, DMAP n  7, parthenolide n  3) (B) Effect of wild-type and
replication-defective Ad5 on ICAM-1 mRNA. Ad5 (800 M.O.I.) incubated at the temperatures indicated for 20 min or Ad. CFTR was added to A549 cells
for 4 h before RNA extraction and ICAM-1 mRNA quantitation. Data are the mean  SEM from three independent experiments. (C) Effect of incubation
temperature on Ad5 genome transcription. The same RNA sample analyzed for the experiment of B were digested with DNase, reverse transcribed, and
amplified to detect the products of E1a region, E2a region (DNA-binding protein), E4-ORFs common sequence, and L5 region (fiber) together with
endogenous ICAM-1 transcript from A549 cells as positive control, as described under Materials and methods. Amplification products were run in ethidium
bromide-stained agarose gels. Lane 1, A549 cells infected with Ad5 incubated at 37°C for 20 min; lane 2, same at 56°C; lane 3, same at 99°C; lane 4, A549
cells mock infected; lane 5, RT-PCR performed with water instead of total RNA, as negative control. (D) Cell proliferation assay in cells exposed to wild-type
Ad5 (800 M.O.I., closed triangles) or mock-infected cells (closed circles). Data are means  SEM (n  3), time course representative of two independent
experiments.
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56°C did not leave infectious particles, the incubation time
was set to 20 min, the shortest time at which the transcrip-
tion of different Ad5 genes, namely Ela, DNA-binding
protein (region E2a), fiber (region L5), and a common
E4-ORFs sequence, was negative (Melotti et al., 2001). As
shown in Fig. 2C, genes of the E1a, E2a, E4, and L5 regions
were transcribed after exposing A549 cells for 4 h to Ad5
(800 M.O.I. incubated for 20 min at 37°C but not at 56 and
99°C. Transcription of E1a region was also excluded after
infecting A549 cells with Ad.CFTR for both 4 h at 800
M.O.I. and 24 h at 200 M.O.I. (data not shown). When
ICAM-1 transcription was measured under the same exper-
imental conditions, Ad.CFTR and Ad5/56°C upregulated
basal ICAM-1 mRNA by twofold, while Ad5 incubated at
37°C increased the transcript levels by fourfold, as reported
in Fig. 2B. These results suggest that activation of ICAM-1
expression can be obtained also in the absence of Ad5
replication, although viral genome transcription adds a ma-
jor incremental contribution to ICAM-1 induction.
Ad5 activates ERK1/2
The fact that Ad5 can stimulate ERK1/2 has been sug-
gested by the results reported on Raf/MAPK stimulation
with a replication-defective Ad5-derived LacZ vector
(Bruder and Kovesdi, 1997) and by the strong inhibitory
effect of PD98059 and AG1288 on Ad5-dependent induc-
tion of ICAM-1 mRNA reported in Fig. 2A. ERK1/2 acti-
vation was first studied by phosphorylation of a peptide
substrate from total cell extracts in the very early period
after addition of wild-type Ad5 or Ad5/56°C. As shown in
Fig. 3A, ERK1/2 was stimulated under both conditions
within a few minutes after exposure, with a peak of maximal
activity ranging from 10 to 30 min. Peak activation of
ERK1/2 was not observed in mock-infected cells (Fig. 3A),
except when phorbol 12-myristate 13-acetate (100 ng/ml for
15 min) was used as positive control (not shown). The
ERK1/2 stimulation observed was verified also by phos-
phorylation of myelin basic protein (MBP) after immuno-
precipitation of ERK1/2, as shown in Fig. 3B and C. There-
fore, we confirm the activation of ERK1/2 within 30 min
from exposure to Ad5.
Ad5 activates JNK1
The JNK/SAPK pathway is known to play an important
role in ICAM-1 gene expression, for instance, in depen-
dence on TNF- transmembrane signaling (De Cesaris et
al., 1999; Kobuchi et al., 1999). Also, the results presented
in Fig. 2A show a dramatic reduction of Ad5-dependent
ICAM-1 mRNA upon incubation of A549 cells with the
JNK/SAPK pathway inhibitor DMAP. Therefore, the phos-
phorylation activity of JNK1 was assayed on c-Jun (1–
169)–glutathione S-transferase (GST) substrate after infec-
tion with Ad5, Ad5/56°C, or virus-free buffer (mock-
infected cells). Western blot analysis was performed to
confirm that the amount of total JNK1 immunoprecipitated
was similar at each time point. TNF- was added in mock-
infected cells as a positive assay control. As shown in Fig.
4, Ad5 and Ad5/56°C stimulate a very neat activation of
JNK1 within 20 to 30 min postexposure, returning to the
basal levels after 60 min.
Ad5 activates p38/MAPK
Because Ad2 has been reported to induce p38/MAPK
(Soumalainen et al., 2001) and the inhibitor SB203580
reduces partially Ad5-dependent ICAM-1 mRNA induc-
tion, we studied p38/MAPK in two different ways. We
carried out a Western blot analysis with a phospho-p38
(P-p38)-specific antibody recognizing the phosphorylation
of threonine 180 and tyrosine 182 of p38/MAPK, which is
known to correlate with activation of this MAPK (Rainge-
aud et al., 1996). As shown in Fig. 5 A and B, the signal of
phosphorylated p38 increases between 10 and 20 min after
addition of Ad5. In parallel, A549 cells exposed to virus-
free buffer (mock-infected cells) did not show increase of
phosphorylation, except upon addition of the positive con-
trol TNF-. Nitrocellulose membranes were stripped, and
the level of total p38 protein was checked by Western blot
analysis with an antibody directed against both phosphory-
lated and dephosphorylated p38 MAPK. Levels of total
p38/MAPK protein did not change significantly, as shown
in Fig. 5A (total p38). To determine whether P-p38 was
functionally active under our experimental conditions, we
assayed p38 kinase activity from total cell extracts with a
MAPKAP kinase-2 substrate peptide. As shown in Fig. 6A,
the activity of MAPKAP (MAPK-activated protein) ki-
nase-2, a downstream substrate of p38 kinase, confirmed a
functional activation peaking 10 to 15 min after Ad5 addi-
tion and returning to basal levels within 30 to 60 min, while
A549 cells exposed to virus-free buffer (mock-infected
cells) did not show significant signal variations. To test
whether transcription-defective heat-inactivated Ad5 is able
to activate p38 MAPK protein, A549 cells exposed to Ad5,
Ad5/56°C, or virus-free buffer were lysed, and MAPKAP
kinase-2 was immunoprecipitated and tested for its phos-
porylation activity toward a MAPKAP kinase-2 substrate
peptide. As shown in Fig. 6B, the phosphorylation signal
did not change in mock-infected cells, while both wild-type
Ad5 and Ad5/56°C stimulated p38 MAPKAP kinase-2 ac-
tivity from 10 to 20 min after exposure.
Ad5 activates nuclear translocation of NF-B
Parthenolide, which is known to inhibit NF-B-depen-
dent gene transcription (Hehner et al., 1999), abolished
Ad5-dependent ICAM-1 mRNA induction, as shown in Fig.
2A. Therefore, the process of NF-B nuclear translocation
was investigated by immunofluorescence, with an antibody
directed against the p65 subunit. NF-B translocation was
studied 4 h following Ad5 exposure, that is after the time of
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activation on MAPKs, which was peaking from 20 to 30
min postexposure. Because viral genome transcription
initiates within 4 h postinfection, replication-defective
Ad.CFTR was utilized together with Ad5 and Ad5/56°C. As
shown in Fig. 7B, the fluorescent signal of the p65 subunit
of NF-B in the absence of Ad5 (virus-free buffer) is
mainly localized in the perinuclear region of the cytoplasm.
Only a faint background signal was observed when the
anti-p65 antibody was replaced with a rabbit preimmune
serum (Fig. 7A). Upon exposure of A549 cells to Ad.CFTR,
Ad5, and Ad5/56°C for 4 h, fluorescence signal becomes
localized in the nuclei, often accompanied by a decrease of
the cytoplasmic signal (Fig. 7C–E), which indicates nuclear
translocation of the NF-B p65 subunit. In contrast, the
signal of p65 remained localized mainly in the perinuclear
region when cells were exposed to Ad5/99°C (Fig. 7F).
Under the conditions described, nuclear translocation of p65
indicating NF-B activation was consistently observed
within the time lapse of 4 h after addition to A549 cells.
Discussion
Early transmembrane signals evoked in the initial phases
of Ad5 infection have been studied in A549 cells focusing
on the upregulation of ICAM-1 mRNA as an adhesion
molecule involved in the inflammatory and immune re-
sponse. The present results demonstrate that incubation of
A549 cells with Ad5: (i) stimulates ERK1/2, p38/MAPK,
and JNK1 very rapidly, 10–30 min after virus addition; (ii)
Fig. 3. Effect of Ad5 on ERK1/2 kinase activity. (A) ERK1/2 kinase measured by phosphorylation of an EGFR-derived synthetic peptide. The
ERK1/2-dependent phosphorylation of a specific peptide substrate containing a sequence of the EGFR was measured in A549 cell lysates obtained at the
indicated times after exposure to wild-type Ad5 (200 M.O.I., filled circles), Ad5 treated at 56°C (200 M.O.I., open circles), or equivalent volumes of virus-free
suspension buffer (open triangles). Radioactivity incorporated at each time is expressed as percentage of counts obtained at time zero (mean 622 cpm, n 
17). Data are means  SEM of n independent experiments (Ad5 n  11, heat-inactivated Ad5 n  3, medium n  3). (B) Phosphorylation of myelin basic
protein (MBP) after immunoprecipitation of ERK1/2. A549 cells were exposed to Ad5 as reported for A and processed as described under Materials and
methods (immunoprecipitation of ERK1/2). To check for homogeneity of the endogenous amount of total ERK1 and ERK2 protein (tERK1 and tERK2),
Western blot analysis was performed as described under Materials and methods (ERK1/2, JNK1, and p38 immunoblots). Coomassie blue staining of the gels
prior to autoradiography showed that all lanes contained similar amounts of MBP substrate (data not shown). Representative autoradiogram and Western blot.
(C) Same as in B after collecting the signal with the video camera. Data are expressed as percentages of the signal obtained at time zero. Representative of
at least three independent experiments.
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stimulates NF-B nuclear translocation within 4 h; and (iii)
upregulates ICAM-1 mRNA levels within 4 h. Moreover,
inhibitors of ERK1/2, JNK, and NF-B pathways reduce or
abolish Ad5-dependent ICAM-1 mRNA upregulation.
These and previous results open the question on whether
Ad5 genome transcription is absolutely necessary to evoke
MAPKs, NF-B, and ICAM-1 induction. Because several
types of E1–E3-deleted recombinant Ad5-derived vectors
have been reported to stimulate Raf/MAPK within 20–30
min postexposure to HeLa cells, it was considered unlikely
the involvement of early viral gene expression in the acti-
vation of this pathway (Bruder and Kovesdi, 1997). The
very rapid activation of ERK1/2, p38, and JNK1 MAPKs
observed a few minutes after exposing A549 cells to Ad5 is
also not likely related to transcription of early viral genes,
because it happens at a time when no viral gene transcrip-
tion is expected. The induction of NF-B and ICAM-1 by
the E1–E3-deleted Ad.CFTR vector is also consistent with
this possibility, although viral replication relevantly contrib-
utes to further ICAM-1 mRNA induction, as shown by the
higher induction obtained after exposing cells to Ad5.
Moreover, we tested the effect of Ad5/56°C, a condition in
which fiber and penton base are dissociated from the viral
capsid (Russell et al., 1967). Interestingly, Ad5/56°C is still
able to induce the three MAP kinase pathways, NF-B, and
ICAM-1 transcript, thus providing a preliminary suggestion
on the potential role of fiber binding in these signaling
pathways. Therefore, the question arises on whether the
interaction of Ad5 fiber or penton base with cell membrane
receptors can be responsible per se for the activation of the
MAPK pathways observed here. Ad5 and Ad2 infection
begins with the binding of the fiber to a 42-kDa glycopro-
tein receptor termed the coxsackie and adenovirus receptor
(CAR), which is localized in the tight junction, and its
biological function is still unknown (Cohen et al., 2001;
Tomko et al., 1997; Bergelson et al., 1998; Roelvink et al.,
1998). Also, we recently demonstrated that heparan sulfate
glycosaminoglycans (HS GAGs) expressed on cell surface
are involved in binding and infection of Ad5 and Ad2
(Dechecchi et al., 2000, 2001). After fiber binding, the
Arg-Gly-Asp (RGD) sequence of the penton base interacts
with v integrins (Wickham et al., 1993), which trigger
virus dismantling and internalization (Wang et al., 1998).
Ad5/2 binding to v integrins induces activation of the Rho
family of small GTPases, p130CAS, and phosphoinositide-
3-OH-kinase, which are required for Ad internalization (Li
et al., 1998, 2000). As far as MAPK pathways are con-
cerned, it has been shown that Ad2 binding through an
Fig. 4. Effect of Ad5 on JNK1 kinase activity. Cell lysates were analyzed for JNK1 activity by an immunocomplex assay using c-Jun (1–169)–GST
recombinant protein as phosphorylation substrate. Representative autoradiogram of phosphorylated substrate (c-Jun-GST) and Western blot of immunopre-
cipitated total JNK (tJNK1) are shown: (A) wild-type Ad5 (200 M.O.I.); (B) Ad5 incubated at 56°C (200 M.O.I.); (C) mock-infected cells (virus-free
suspension buffer). TNF- (50 ng/ml), as a positive control in mock-infected cells, was incubated for 30 min.
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integrin-independent receptor activates p38/MAPK, which
is involved in intracellular virus trafficking (Soumalainen et
al., 2001), and that Ad5 and Ad2 stimulate the ERK1/2
pathway, which has no impact on the trafficking of the
incoming virus particles (Bruder and Kovesdi, 1997; Soum-
alainen et al., 2001). Interestingly, an Ad5 capsid-dependent
induction of the chemokine IP-10 has been shown to in-
volve activation of ERK1/2, p38 MAPK, and NF-B
(Borgland et al., 2000; Tibbles et al., 2002). Therefore, the
present results extend the knowledge on the early signals
evoked by interaction of Ad2/5 with cell membrane. While
some of them are known to be dependent on integrin-
mediated signaling, the role of the other receptors such as
CAR and cell surface HS GAGs in the activation of the
three MAPK pathways remains to be addressed.
The role of the early signaling events in entry and intra-
cellular trafficking of Ad5/2 into infected cell has been well
described for Rho family of small GTPases, p130CAS, phos-
phoinositide-3-OH-kinase, and p38/MAPK (Li et al., 1998,
2000; Soumalainen et al., 2001). On the other hand, ERK1/2
does not seem required in these processes and no informa-
tion is available for JNK1 (Soumalainen et al., 2001).
Therefore, the possibility opens that ERK1/2 and JNK are
involved in the induction of the inflammatory response
following Ad2/5 infection, such as the expression of
ICAM-1 (Stark et al., 1996; Nicolis et al., 1998). For in-
stance, the Ad5-dependent activation of Raf/MAPK has
been implicated in the production of the proinflammatory
cytokine interleukin-8 (Bruder and Kovesdi, 1997). In this
respect, it should be noted that ICAM-1 promoter comprises
Fig. 5. Effect of Ad5 on p38 phosphorylation. (A) A549 cells were incubated with Ad5 or virus-free suspension buffer (mock infected). TNF- (50 ng/ml),
as positive control, was incubated with cells for 30 min. P-p38, the same amounts of protein from cell extracts were analyzed by immunoblotting with an
antibody specifically recognizing the activated form of p38, which is phosphorylated on Thr-180 and Tyr-182. Total p38, membranes utilized in Western
analysis were stripped and incubated with an antibody directed against both phosphorylated and dephosphorylated p38, to check for homogeneity of total
p38 analyzed with Western blot. (B) Quantitative measurements of phosphorylated p38 were obtained as reported in the previous figures. Representative of
three independent experiments.
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several potential sequences for binding of MAPK-depen-
dent nuclear transcription factors, such as AP-1, Ets-1,
C/EBP, and AP-1/Ets (Cohen, 1997; Roebuck and
Finnegan, 1999). The results reported here indicate a close
relation between MAPK and ICAM-1 mRNA upregulation,
because the latter is almost completely abolished by inhib-
itors of MEK1 and JNK and largely reduced by inhibitors of
ERK1/2 and p38/MAPK. Therefore, Ad5 cell membrane
interaction rapidly induces a redundant series of MAPKs,
which can cooperate in the activation of the proinflamma-
tory adhesion molecule ICAM-1.
The present results demonstrate that both wild-type and
transcription-defective heat-inactivated Ad5 stimulate
NF-B nuclear translocation and ICAM-1 mRNA upregu-
lation within 4 h postaddition. The complete inhibition of
ICAM-1 upregulation obtained with parthenolide indicates
the involvement of NF-B in ICAM-1 gene induction even
in the early-intermediate phase of viral binding and entry.
This opens the question on whether the very rapid activation
of the three MAPK pathways stimulates NF-B nuclear
translocation. The induction of NF-B by the MEKK1 and
MKK6 kinases, which are known to be upstream of ERK1/2
and p38/MAPK, has been recently reported (Craig et al.,
2000; Baumann et al., 2000). Also, ERK is known to phos-
phorylate and activate the p90 ribosomal S6 kinase, which
in turn has been reported to phosphorylate IB, resulting
in subsequent activation of NF-B (Schouten et al., 1997;
Poteet-Smith et al., 1999). Therefore, it should be taken into
consideration that induction of NF-B can intervene also in
dependence on MAPKs activation. The present results show
that the separate incubation of the ERK1/2 pathway inhibitor
PD98059, of the JNK pathway inhibitor DMAP, and of the
NF-B inhibitor parthenolide is able to abolish the Ad5-de-
pendent ICAM-1 upregulation. This can be explained by a lack
of specificity of these inhibitors, although this has been re-
cently excluded in A549 cells (Chen et al., 2000). Alterna-
tively, these results suggest that MAPKs and NF-B activation
induces ICAM-1 upregulation by a sequential process, which
can be blocked at different levels by each single inhibitor. The
MAPK–NF-B sequential model has been already demon-
strated in respiratory epithelial cells, in which ERK1/2 induces
gene transcription through RSK-dependent activation of
NF-B (Li et al., 1998). Considering that inhibition of JNK
pathway, which does not seem included in this sequential
model, abolishes Ad5-dependent ICAM-1 mRNA induction,
the model proposed above only fits our results in part. How-
ever, it is possible to consider that ICAM-1 mRNA upregula-
tion induced in the early phase by Ad5 involves the binding of
more than a single nuclear transcription factor to the ICAM-1
promoter and specifically requires both NF-B and a JNK-
dependent transcription factor.
In conclusion, MAPK activation plays a key role in the
induction of the very early mechanisms of activation of the
proinflammatory adhesion molecule ICAM-1. Whether
MAPKs are responsible for the induction of other genes
involved in the inflammatory response, besides ICAM-1
and interleukin-8, will require further investigation. More-
over, the identification of the viral structures responsible for
MAPKs induction will provide useful information to adopt
strategies aimed at circumventing the inflammatory re-
sponse induced by Ad-derived vectors under development
for gene therapy.
Fig. 6. Effect of Ad5 on p38 kinase activity. (A) The activity of p38 was
measured with an assay kit based on the determination of MAPKAP
kinase-2 activity, which is dependent on its phosphorylation by p38, as
described under Materials and methods (ERKs and p38 activity assay). Cell
lysates, obtained at the indicated times after exposure to Ad5 or virus-free
buffer as negative control, were incubated with 10 Ci [-32P]ATP and the
substrate peptide KKLNRTLSVA. Radioactivity incorporated at each time
is expressed as percentage of counts obtained at time zero (mean 50,300
cpm, n  4). Data are expressed as means  SEM of two independent
experiments. (B) The activity of p38 was measured as above reported after
immunoprecipitation with a polyclonal antibody directed toward MAP-
KAP kinase-2. Cell lysates (40 g/sample) obtained at the indicated times
after exposure to Ad5 (filled circles), Ad5 incubated at 56°C (filled trian-
gles), or virus-free medium as negative control (mock infected, open
circles) were incubated with an anti-MAPKAP kinase-2 antibody bound to
protein A/G Plus–Agarose beads. Beads carrying the immunocomplex
were washed and incubated with the substrate peptide KKLNRTLSVA
with the same procedure described for immunoprecipitation of ERK1/2
under Materials and methods. Radioactivity incorporated at each time is
expressed as percentage of counts obtained at time zero (mean 69,943 cpm,
n  9). Data are expressed as means  SEM of three independent
experiments.
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Materials and methods
Cell culture, virus production, cell infection, and
proliferation assay
A549 cells were obtained from American Type Culture
Collection (ATCC, Manassas, VA) and maintained in Dul-
becco’s modified Eagle’s medium (DMEM) supplemented
with 10% low endotoxin fetal bovine serum (FBS) (Bio-
Whittaker, Walkersville, MD), at 37°C in a 5% CO2/95%
air humidified atmosphere. Ad5 was obtained as stock
from ATCC and propagated in A549 cells. The E1–E3-
deleted Ad5-derived vector carrying the cystic fibrosis gene
Ad.CFTR was obtained as stock from Transgene SA (Stras-
Fig. 7. Ad5-dependent nuclear translocation of NF-B. A549 cells were incubated for 4 h at 200 M.O.I. with Ad.CFTR (C); Ad5 incubated at 37°C (D), 56°C
(E), or 99°C (F); or virus-free buffer (A and B) as described under Materials and methods s (immunofluorescent staining of NF-B). Slides were incubated
with a primary antibody directed against NF-B p65 subunit (B–F) or rabbit preimmune antibody (A). Representative of three independent experiments.
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bourg, France) and propagated in 293 cells (Rosenfeld et al.,
1992). The viruses were purified by four freeze–thawing
cycles, followed by two successive bandings on CsCl gra-
dients (Precious and Russell, 1995). Purified virus was di-
alyzed against 10 mM Tris–HCl (pH 8) and 1 mM MgCl2,
aliquoted with the addition of 10% glycerol (virus suspen-
sion buffer), and stored at 80°C until use. The titer of the
viral stock was determined by plaque assay in A549 cells
and expressed as plaque-forming units (PFU) (Graham and
Van Der Eb, 1973). Infection doses are expressed as mul-
tiplicity of infection (M.O.I.), where 1 M.O.I. corresponds
to 1 PFU/cell. For ICAM-1 and MAPK studies, A549 cells
grown on 60-mm-diameter dishes were starved for 18 h in
serum-free DMEM (3 ml), so as to avoid activation of
MAPKs by the growth factors contained in the serum. After
starvation, part of the medium (2 ml) was removed and virus
suspension (10–20 l) containing wild-type Ad5, heat-in-
activated Ad5 (56°C for 20 min), or an equivalent volume
of virus-free suspension buffer was added to the remaining
1 ml of serum-free medium and incubated at 37°C in a 5%
CO2/95% air humidified atmosphere for the time indicated.
To exclude cell toxicity due to exposure to Ad5 and quan-
tify cell proliferation and viability, the cell proliferation
assay kit (Chemicon International) was used according to
the manufacturer’s instructions. The assay is based on the
cleavage of the tetrazolium salt WST-1 to formazan by
cellular mitochondrial dehydrogenases, which is a function
of the expansion of the number of the viable cells. The
production of formazan has been measured by absorbance at
440 nm. Cells cultured in 96-well microtiter plates have
been incubated with virus-free buffer or with Ad5 at 37°C
for up to 4 h. After this period, the tetrazolium salt was
added (10 l each well), and absorbance was measured at
the time indicated.
Signal transduction inhibitors
Tyrphostin AG1288, PD98059 (2-(2-amino-3-
methoxyphenyl)oxanaphthalen-4-one), and SB203580
(4-(4-fluorophenyl)-2-(4-ethylsulfinyl)-5-(4-pyridyl)1h-
imidazole) were obtained from Calbiochem (La Jolla, CA).
DMAP and parthenolide were obtained from Sigma (St.
Louis, MO). Stock solutions of AG1288 (200 mM),
PD98059 (50 mM), SB203580 (10 mM), parthenolide (10
mM) in dimethyl sulfoxide (DMSO), and DMAP (1 M) in
H2O were stored at 20°C. All the inhibitors were diluted
into DMEM before addition to cells. A549 cells grown on
four-well plastic multidishes (2  105 in 2-cm diameter)
were starved in serum-free DMEM for 18 h and incubated
with the inhibitors prior to infection. The equivalent con-
centrations of DMSO utilized with the inhibitors were
added in all paired control samples. After incubation with
the inhibitors, Ad5 (800 M.O.I.) was added to cells for 4 h
in serum-free DMEM (containing the inhibitors). Cells were
then washed with phosphate-buffered saline (PBS) and
lysed for total RNA extraction.
ICAM-1 and viral gene expression by RT-PCR
Single-tube competitive RT-PCR quantitation of
ICAM-1 mRNA was obtained from total RNA extracted
with the High Pure RNA isolation kit (Roche, Mannheim,
Germany) according to the supplier’s instructions. Total
RNA was treated with RNase-free RQ1 DNaase (Promega,
Madison, WI) following the supplier’s instructions and an-
alyzed for ICAM-1 gene expression by competitive RT-
PCR analysis (Pannetier et al., 1993), according to the
procedure described previously (Nicolis et al., 1998).
Briefly, total RNA was reverse-transcribed and amplified by
PCR in the presence of the homologous competitor. The
PCR products were further amplified, and the final ampli-
fication was subjected to the run-off reaction. The fluores-
cent products obtained were run in an Applied Biosystem
373A DNA sequencer (Perkin–Elmer Applied Biosystems,
Foster City, CA). The sizes of the target and competitor
were 110 and 105 bp in length, respectively. Peak area and
length of the labeled PCR fragments were determined with
GeneScan software (Perkin–Elmer Applied Biosystems).
Competitor over target areas were plotted on the y-axis
versus the number of copies of competitor (x-axis) and fitted
by least-square regression analysis to quadratic equations by
Sigma Plot software (Jandel Scientific, Erkrath, Germany).
Expression of the E1a, E2a, E4, and L5 viral gene tran-
scripts was obtained from the same aliquots of total RNA
extracted from infected A549 cells using a very sensitive
assay such as nested RT-PCR, as previously described
(Melotti et al., 2001). E1a transcript was performed with the
same nested RT-PCR method by using the following
couples of direct (D) and reverse (R) primers: Ad5E1aD1
5-TCGCGGGAAAACTGAATAAGAGG-3 (nt 277–299);
Ad5E1aR1 5-CCTCCGGTACAAGGTTTGGCATAG-3
(nt 891–914); Ad5E1aD2 5-TCTTGAGTGCCAGCGAG-
TAGAGTT-3 (nt 501–524); and Ad5E1aR2 5-TCCTG-
CACCGCCAACATTACAGAGT-3 (nt 762–786). Nucle-
otide positions are from accession number X02996.1 (GI:
58484). The completeness of viral DNA digestion was
checked by subjecting each sample to nested PCR before
proceeding with reverse transcription. The amplified prod-
ucts were loaded on ethidium bromide-stained agarose gels.
Specificity of the amplified products was confirmed by
restriction analysis using NarI endonuclease for E1a and E4,
EcoRV for E2a, and HindIII for fiber product.
Fluorescent focus assay
Infection efficiency was quantified as previously de-
scribed (Wickham et al., 1993; Dechecchi et al., 2000).
Briefly, A549 cells were seeded onto chamber slides and left
to reach confluence, to obtain a standard surface area. The
cells were starved in serum-free DMEM for 18 h and then
treated with the inhibitors as described. Ad5 (10 M.O.I.)
was added and incubated for 4 h, the inoculum was re-
moved, and the wells were washed twice with PBS before
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overnight incubation with tissue culture medium. Cells were
fixed and permeabilized with acetone, blocked with 10%
pig serum in PBS for 30 min, and incubated with a primary
antibody directed against Ad hexon protein (Chemicon) at
1:100 dilution in 10% pig serum/PBS for 1 h. After wash-
ing, cells were incubated for 30 min with 1:100 dilution of
fluorescein isothiocyanate-conjugated rabbit anti-mouse an-
tibody (Sigma) in 1% Evans blue in PBS. Fluorescent foci
were counted with a Nikon TMD microscope.
Preparation of cell lysates
After 18 h of starvation, cells were infected as indicated
above and then washed three times with ice-cold PBS,
scraped, and collected by centrifugation at 13,000g for 5
min at 4°C. The pellet was suspended in RIPA buffer (50
l) containing 20 mM Tris–HCl (pH 7.4), 137 mM NaCl, 2
mM ethylenediaminetetraacetic acid (EDTA), 10% glyc-
erol, 0.1% sodium dodecyl sulfate (SDS), 0.5% deoxycholic
acid, 1% Triton X-100, 25 mM -glycerol phosphate, 1 mM
Na3VO4, 20 M leupeptin, 0.2 mM phenylmethylsulfonyl
fluoride (PMSF), 25 g/ml aprotinin and incubated for 30
min at 4°C. Cell lysate was cleared by centrifugation at
13,000g for 20 min at 4°C. Protein concentration was de-
termined by the method of Lowry et al. (1951) after pre-
cipitation with 5% trichloroacetic acid, utilizing bovine se-
rum albumin as a standard. Aliquots were stored at 80°C.
ERKs and p38 activity assay
The activity of ERK1/2 was determined with the Biotrak
MAP kinase assay (Amersham Pharmacia Biotech) accord-
ing to the manufacturer’s instructions. Briefly, cell lysates
(10 g protein/15 l aliquots) were incubated at 30°C for
30 min with 10 l of a synthetic peptide substrate contain-
ing a sequence of the epidermal growth factor receptor
(EGFR) with a single phosphorylation site for ERK1/2. The
reaction was started by adding 1 Ci/5 l of Mg-[-
32P]ATP (Amersham) and stopped with 10 l of stop re-
agent. Samples were spotted on 3-cm-diameter disks of
binding paper. After washing twice in 1% acetic acid and
twice in water, disks were placed in scintillation vials, and
radioactivity was counted in a Packard Tri-Carb 2100 TR
liquid scintillation analyzer. Counts from the endogenous
protein phosphorylation and nonspecific binding of
[-32P]ATP to filter were subtracted. Activity of p38 was
based on the determination of MAPKAP kinase-2 activity,
which is dependent on its phosphorylation by p38
(Miyazawa et al., 1998), with a kit provided by Upstate
Biotechnology (Lake Placid, NY). Sample aliquots (10 g
protein) or MAPKAP kinase-2 as positive control (5 l
corresponding to 0.1–0.5 Units) were incubated at 30°C in
assay buffer (60 l) containing 10 l of MAPKAP kinase-2
substrate peptide related to human glycogen synthase amino
acid sequence 1 to 9 (KKLNRTLSVA) and 10 l of Mg-
[-32P]ATP (10 Ci). After 30 min, 30-l aliquots were
transferred on P-81 paper squares and washed three times
with 0.75% phosphoric acid and once with acetone, and
radioactivity was counted as above described. Active MAP-
KAP kinase-2 was immunoprecipitated from the same ly-
sates (40 g of protein each sample) obtained from cells
incubated with Ad5, heat-inactivated virus, or virus-free
medium with a polyclonal antibody directed against MAP-
KAP kinase-2 (sheep polyclonal IgG) bound to protein A/G
Plus agarose (Santa Cruz Biotechnology, Santa Cruz, CA).
Mock immunoprecipitation was obtained with irrelevant
sheep IgG. MAPKAP kinase-2 enzyme activity was mea-
sured by incubation of the immunoprecipitate with a spe-
cific peptide substrate and [-32P]ATP to as above de-
scribed.
Immunoprecipitation of ERK1/2 and JNK1
Aliquots of cell lysates (50 g of protein each sample)
were incubated for 2 h at 4°C with 10 g/ml anti-ERK1 and
ERK2 polyclonal antibody (Santa Cruz Biotechnology) in
100 l of RIPA buffer. Samples were then incubated over-
night at 4°C with 10 l protein A–Sepharose CL-4B (Phar-
macia Biotech, Uppsala, Sweden) in 100 l of RIPA buffer.
Immune complexes bound to Sepharose beads were washed
twice with RIPA buffer, again with 0.5 M LiCl, 0.1 M
Tris–HCl (pH 8), and finally with kinase assay buffer (25
mM HEPES, 25 mM -glycerol phosphate, 1 mM dithio-
threitol, 10 mM MgCl2, 1 mM Na3VO4, 20 M leupeptin,
0.2 mM PMSF, 25 g/ml aprotinin, pH 7.4). Beads were
incubated with 10 g/40 l MBP (Sigma) as substrate and
10 M ATP, 10 Ci [-32P]ATP in kinase assay buffer at
30°C for 30 min. Similarly to ERK1/2, it was immunopre-
cipitated with 10 g/ml anti-JNK polyclonal antibody (San-
ta Cruz Biotechnology) in 100 l of RIPA buffer. Samples
were then incubated overnight at 4°C with 10 l protein
A–Sepharose CL-4B. Sepharose beads were washed three
times with RIPA buffer and two times with kinase buffer
and then incubated for 30 min at 30°C in 30 l containing
1 g c-jun (1–169)–GST as substrate (Upstate Biotechnol-
ogy), 5 Ci [-32P]ATP, 10 M ATP, in assay dilution
buffer (20 mM MOPS, pH 7.2, 25 mM -glycerol phos-
phate, 5 mM EGTA, 1 mM dithiothreitol, 1 mM Na3VO4).
Phosphorylation reactions were terminated by dilution with
5 SDS–polyacrylamide gel electrophoresis (PAGE) sam-
ple buffer. After being boiled for 3 min at 95°C, samples
were clarified by centrifugation and 32P-labeled MBP and
c-Jun (1–169)–GST products were separated on 15 or 10%
SDS–polyacrylamide gels, respectively, and subjected to
autoradiography. Phosphorylation bands on X-ray films
were collected with a Hamamatsu C2400-97 CCD video
camera (Hamamatsu City, Japan) and quantified with Opti-
lab Concept V.i. software (Graftek, France).
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ERK1/2, JNK1, and p38 immunoblots
ERK1, ERK2, and JNK1 protein levels were measured
from the same cell lysates used for kinase assay. Aliquot
samples (10 g of protein each) were suspended in SDS–
PAGE sample buffer, boiled for 3 min at 95°C, subjected to
10% SDS–PAGE, and transferred to nitrocellulose mem-
branes (0.2-m pore diameter) (Pharmacia Biotech) in 25
mM Tris–HCl, pH 8.3, 192 mM glycine, 0.1% SDS, 20%
methanol. Membranes were blocked in Tris-buffered saline
containing 5% nonfat dried milk and 0.1% Tween 20 for 1 h
at room temperature. Polyclonal antibodies specific for
ERK1, ERK2, and JNK1 (Santa Cruz Biotechnology) were
diluted 1:100 in the same solution and added for 1 h at room
temperature or overnight at 4°C. Antibody specificity was
checked by competitive binding in the presence of 10 g/ml
of target peptide sequences of ERK1/2 or p38/MAPK. After
three washes with Tris-buffered saline containing 0.1%
Tween 20, membranes were incubated with horseradish
peroxidase-coupled anti-rabbit IgG (Amersham) at a 1:5000
dilution of Tris-buffered solution containing 1% BSA and
0.1% Tween 20 for 1 h at room temperature and then
washed three times for 5 min. Signal was developed by
enhanced chemiluminescence (ECL kit, Amersham Phar-
macia Biotech). To detect p38 phosphorylation, cell lysates
(20 g) were resolved by SDS–PAGE and transferred to
membranes as described above. Membranes were blocked
with Tris-buffered solution containing 5% BSA and 0.1%
Tween 20 for 1 h at room temperature and then incubated
with a 1:1000 dilution of a polyclonal antibody directed
against the phosphorylated form of Thr 180 and Tyr 182 of
p38 MAPK (Phospho-p38 MAP kinase Thr180/Tyr182 an-
tibody, New England Biolabs, Beverly, MA) for 16 h at
4°C. Excess antibodies were washed at room temperature,
and signal was developed by ECL. The same membrane was
stripped using as denaturating solution 7 M guanidine–HCl,
2 mM EDTA, 50 mM dithiothreitol, 50 mM Tris–HCl, pH
7.5, for 1 h at room temperature and as renaturating solution
50 mM Tris–HCl, pH 7.5, 100 mM NaCl, 2 mM EDTA, 2
mM dithiothreitol, 0.1% Tween 20, for 12 h at 4°C. Mem-
branes were washed extensively with PBS. To detect p38
protein levels, the stripped membranes were incubated with
a polyclonal antibody to p38 (Santa Cruz Biotechnology)
diluted 1:100 in Tris-buffered saline (TBS, 20 mM Tris–
HCl, pH 7.4, 137 mM NaCl) containing 5% bovine serum
albumin and 0.1% Tween 20. Membranes were washed, and
signal was developed as above. The quantification of total
ERK1, total ERK2, total JNK1, total p38, and phospho-p38
was performed by video camera and image analysis as
described above.
Immunofluorescent staining of NF-B
A549 cells were seeded on eight-well chamber slides
(Nunc, Naperville, IL) treated with 10 g/ml purified col-
lagen (Vitrogen-100, Collagen Corporation, Palo Alto, CA)
for 2 h in complete DMEM supplemented with 10% FBS.
A549 cells were starved for 18 h in serum-free DMEM, and
then Ad5 incubated at 37, 56, or 99°C for 20 min was added
at 200 M.O.I. in a volume of 10–20 l of suspension buffer
and left in place for an additional 4 h. Mock-infected cells
were exposed to the equivalent volume of virus-free sus-
pension buffer and treated as described. Cells were washed
three times with PBS and fixed with 4% paraformaldehyde
(w/v) in PBS for 20 min at room temperature. After three
washes with PBS, cells were permeabilized with methanol
at 20°C for 6 min and then air-dried for 1 h. Slides were
incubated with 5% BSA in PBS for 90 min at room tem-
perature and then subjected to three 1-h incubations at room
temperature with 7 g/ml rabbit polyclonal antibody against
NF-B p65 subunit (sc-109, Santa Cruz Biotechnology) or
preimmune rabbit IgG in 1% BSA, a 1:200 dilution of
biotinylated goat anti-rabbit IgG (Santa Cruz Biotechnol-
ogy) in 1% BSA/PBS, and a 1:50 dilution of fluorescein
isothiocyanate-conjugated streptavidin (Sigma) in 1% BSA/
PBS. Coverslips were mounted with Prolong antifade (Mo-
lecular Probes, Eugene, OR and stored at room temperature.
Fluorescence was examined with a Nikon TMD micro-
scope. Specificity of the signal was checked by excluding
the presence of fluorescence with a rabbit preimmune serum
instead of the sc-109 primary antibody (data not shown).
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